Citigroup’s Medifast MED Stock Holding History

Citigroup’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-54,000	Closed	-$2.07M	–	5704
2024 Q1	$2.07M	Buy	+54,000	New	+$2.62M	﹤0.01%	2410
2013 Q3	–	Sell	-40,000	Closed	-$1.03M	–	6903
2013 Q2	$1.03M	Buy	+40,000	New	+$1.05M	﹤0.01%	2877

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup's MED Position: Q2 2026 in Review

Citigroup sold out of Medifast (MED) in Q2 2026, closing a stake of 3,599 shares — an estimated $36.7K sold.

Citigroup first reported a position in MED in Q2 2013 and held it in 52 quarters. The position peaked at $3.13M in Q2 2021. 112 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Citigroup reported no remaining Medifast position as of Q2 2026 after selling out during the quarter.
Citigroup sold 3,599 Medifast shares in Q2 2026, an estimated $36.7K.
Citigroup first reported a position in Medifast in Q2 2013 and held it in 52 quarters.
Citigroup's Medifast position peaked at $3.13M in Q2 2021.
112 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.